How does a fractional CRO fix forecasting at a medical device company in 2027?

Question

Pulse · Accepted Answer

![How does a fractional CRO fix forecasting at a medical device company in 2027?](/assets/cro-cover-4.jpg)

# How does a fractional CRO fix forecasting at a medical device company in 2027?

```answer
A fractional CRO fixes forecasting by installing a repeatable, data-verified pipeline process that replaces wishful thinking with stage-gate rigor. For a medical device company in 2027, expect a fractional CRO engagement to cost between $8,000 and $18,000 per month for a 2-3 day per week commitment, depending on the complexity of the sales cycle, the number of revenue channels, and the founder's willingness to trade cash for equity.
```

## Direct Answer

Forecasting in medical device sales is notoriously broken because the buying process involves multiple clinical, economic, and administrative stakeholders, each with their own timeline. A fractional CRO doesn't fix this by guessing harder — they fix it by defining a clear set of **pipeline stages** with objective exit criteria, then auditing every deal against those criteria weekly. The result is a forecast that shows you where your revenue actually stands, not where you hope it will be. This work typically takes 60-90 days to install and another quarter to stabilize, and it requires the CEO to grant the fractional CRO direct access to your CRM data and the authority to challenge sales reps on stage progression.

```steps
title: How to fix forecasting at a medical device company in 2027
- Audit current CRM data | Clean Salesforce or HubSpot records, remove stale deals, and tag each opportunity with the correct stage and last activity date.
- Define stage-gate criteria | Write objective, binary exit criteria for each pipeline stage (e.g., "Clinical trial results shared and reviewed" instead of "Engaged with clinician").
- Install a weekly pipeline review | Hold a 60-minute session where every deal above a threshold is reviewed against the criteria — no exceptions.
- Train reps on qualification | Teach the sales team to use a scoring system (e.g., MEDDICC or BANT) that matches the medical device buying committee structure.
- Build a weighted forecast model | Apply a probability to each stage based on historical close rates, not gut feel, and update it quarterly.
- Create a risk register | Identify the top three risks to the current forecast each week and assign an owner for each.
```

## Why medical device forecasting is harder than SaaS forecasting

Medical device companies face a **multi-threaded sale** that involves surgeons, hospital administrators, procurement departments, and sometimes GPOs (Group Purchasing Organizations). Each stakeholder has different incentives: surgeons want clinical outcomes and ease of use, administrators want cost savings and reimbursement codes, and procurement wants contract compliance. A typical SaaS forecast assumes a single economic buyer with a linear timeline — that model breaks down completely in medtech.

A fractional CRO brings **buyer-mapping experience** from other complex sales environments (capital equipment, enterprise SaaS, life sciences tools) and applies it to your specific stakeholder list. They will insist that your CRM reflects these multiple contacts per deal, with each contact's influence level and stage of engagement tracked separately. Without that data, your forecast is a fiction.

## The three fixes a fractional CRO applies first

**Fix #1: Clean the pipeline.** Most medical device companies have deals that are six months old with no activity, still sitting at "Discovery." The fractional CRO will either move them to a realistic stage or close them out. This alone can cut your reported pipeline by 30-50%, which is painful but honest.

**Fix #2: Install stage-gate criteria.** The fractional CRO will write a one-page document that defines exactly what must happen for a deal to move from "Clinical Evaluation" to "Proposal." For example, "Clinical champion has confirmed a trial date with the OR committee" — not "Surgeon is interested." These criteria are **binary**, not subjective.

**Fix #3: Build a weighted forecast.** Instead of asking reps "What's your confidence level?" (which produces 90% on everything), the fractional CRO will assign a probability to each stage based on your actual historical close rates. If 40% of deals at "Proposal" stage have closed in the past, then every deal at that stage is worth 40% of its value in the forecast. This removes the emotional bias.

How does a fractional CRO fix forecasting at a medical device company in 2027?

Direct Answer

Why medical device forecasting is harder than SaaS forecasting

The three fixes a fractional CRO applies first

How the fractional CRO works with your existing team

The role of tools in 2027

How to measure success

When a fractional CRO is not the right answer

FAQ

Sources

How does a fractional CRO fix forecasting at a medical device company in 2027?

Direct Answer

Why medical device forecasting is harder than SaaS forecasting

The three fixes a fractional CRO applies first

How the fractional CRO works with your existing team

The role of tools in 2027

How to measure success

When a fractional CRO is not the right answer

FAQ

Sources

What does the score mean?